About me: I got my bachelor’s degree in Physics in 2019 at the University of Sevilla and then, I obtained access to the double master’s program in Nuclear Physics between the University of Sevilla and the Westfälische Wilhelms-Universität Münster (WWU). During this program, from September 2019 to February 2020, I studied at different Universities in Spain (Universidad Complutense de Madrid (UCM), Universidad de Granada (UGR), and Universidad de Sevilla (US). Then, in March 2020, I went to Münster (Germany) to develop my master’s thesis project, which took place in the Research Group of Alexander Kappes (Institut für Kernphysik, WWU). Later, in July 2021, I started my PhD project under the supervision of Miguel A. Cortes-Giraldo (University of Sevilla, Spain) and Alejandro Bertolet (Massachusetts General Hospital and Harvard Medical School, Boston, USA), which is focused on the study of radiopharmaceutical therapy in the framework of microdosimetry and radiobiological models for this kind of treatments.

Research Interests: My recent research is centered around proton radiotherapy and radiopharmaceutical therapy treatments. The development of the field heavily relies on the utilization of radiobiological models that can accurately replicate both in-vitro and in-vivo experimental data from assays and treatment procedures. To achieve this objective, I have a particular interest in microdosimetry models specifically designed for such treatments, as well as in utilizing Monte-Carlo simulations with Geant4, Geant4-DNA, and TOPAS toolkits.